TERRA, a Multifaceted Regulator of Telomerase Activity at Telomeres.


Journal

Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R

Informations de publication

Date de publication:
10 07 2020
Historique:
received: 29 10 2019
revised: 06 02 2020
accepted: 10 02 2020
pubmed: 23 2 2020
medline: 23 1 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

In eukaryotes, telomeres are repetitive sequences at the end of chromosomes, which are maintained in a constitutive heterochromatin state. It is now known that telomeres can be actively transcribed, leading to the production of a telomeric repeat-containing noncoding RNA called TERRA. Due to its sequence complementarity to the telomerase template, it was suggested early on that TERRA could be an inhibitor of telomerase. Since then, TERRA has been shown to be involved in heterochromatin formation at telomeres, to invade telomeric dsDNA and form R-loops, and even to promote telomerase recruitment at short telomeres. All these functions depend on the diverse capacities of this lncRNA to bind various cofactors, act as a scaffold, and promote higher-order complexes in cells. In this review, it will be highlighted as to how these properties of TERRA work together to regulate telomerase activity at telomeres.

Identifiants

pubmed: 32084415
pii: S0022-2836(20)30154-6
doi: 10.1016/j.jmb.2020.02.004
pii:
doi:

Substances chimiques

RNA, Long Noncoding 0
Telomerase EC 2.7.7.49

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4232-4243

Subventions

Organisme : CIHR
ID : MOP-89768
Pays : Canada
Organisme : CIHR
ID : PJT-162156
Pays : Canada

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Maxime Lalonde (M)

Department of Biochemistry and Molecular Medicine, Université de Montréal, Quebec, Canada.

Pascal Chartrand (P)

Department of Biochemistry and Molecular Medicine, Université de Montréal, Quebec, Canada. Electronic address: p.chartrand@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH